CN Patent

CN106880614A — 一种萘普生缓释片及其制备方法

Assigned to Chengdu Diao Pharmaceutical Group Co Ltd · Expires 2017-06-23 · 9y expired

What this patent protects

本发明公开了一种萘普生缓释片剂及其制备方法，其包含活性成分萘普生和药用辅料，所述药用辅料为羟丙甲纤维素、乳糖、碳酸氢钙、滑石粉和硬脂酸镁。本发明方法简单易行，得到的产品能持久的释放有效成分并使血药浓度保持平稳，其峰浓度和谷浓度变化范围小，减少服药剂量和次数，副作用低。

USPTO Abstract

本发明公开了一种萘普生缓释片剂及其制备方法，其包含活性成分萘普生和药用辅料，所述药用辅料为羟丙甲纤维素、乳糖、碳酸氢钙、滑石粉和硬脂酸镁。本发明方法简单易行，得到的产品能持久的释放有效成分并使血药浓度保持平稳，其峰浓度和谷浓度变化范围小，减少服药剂量和次数，副作用低。

Drugs covered by this patent

dextromethorphan-hydrobromide (DEXTROMETHORPHAN HYDROBROMIDE)

Patent Metadata

Patent number: CN106880614A
Jurisdiction: CN
Classification: —
Expires: 2017-06-23
Drug substance claim: No
Drug product claim: No
Assignee: Chengdu Diao Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.